Pharmaceuticals
Pharmaceuticals encompass the research, development and manufacturing of drugs for disease treatment and prevention by applying chemistry, pharmacology and medical science. Effective medications and therapies are critical to enhancing patient health outcomes. These medications continue to improve based on growing knowledge of biochemical processes and drug interactions.
Top Stories
-
News
15 Aug 2024
CMS reaches agreements for lower prices of 10 drugs
The negotiated prices mark a 38–79% discount off of list prices that could save roughly $6 billion annually. Continue Reading
-
Feature
12 Aug 2024
Exploring trends shaping the future of specialty pharmacy
The pharmacy industry is evolving with specialty drugs, requiring advanced management and technology solutions to control costs and improve patient outcomes. Continue Reading
-
News
09 Aug 2024
40% of Americans say pediatric vaccinations are extremely important
Data from a Gallup poll revealed that fewer Americans regard childhood vaccinations as important or extremely important. Continue Reading
-
News
26 Jul 2024
Boar's head recalls 200K pounds of deli meat due to Listeria risk
Boar's Head recalls 200,000 pounds of deli meat over potential Listeria contamination linked to a multi-state outbreak. Continue Reading
-
Feature
17 Jun 2024
2023 USP Report highlights economic factors driving drug shortages
The USP's 2023 report links drug shortages to economic factors, urging policy reforms, pricing adjustments, and supply chain diversification. Continue Reading
-
News
11 Jun 2024
Combined COVID-19/influenza vaccine is superior to individual vaccines
Moderna’s mRNA-1083 vaccine combines the company’s seasonal influenza candidate and next-generation COVID-19 vaccines for improved immune response. Continue Reading
-
Answer
13 May 2024
Defining vaccine hesitancy, understanding how to address it
Hilary Hatch, PhD, explores the different aspects of vaccine hesitancy and offers solutions for addressing ongoing issues. Continue Reading
-
Feature
30 Apr 2024
Exploring the top 20 biopharma companies Q1 2024 market cap growths
Of the top 20 biopharmaceutical companies to see a profitable Q1 in 2024, Lilly leads with a 33.7% increase, with Nordisk in second, outperforming Johnson & Johnson. Continue Reading
-
Feature
23 Apr 2024
Discovering 6 applications of bioinformatics in drug repurposing
Bioinformatics plays a critical role across pharmaceutical innovation, with many applications in drug discovery and repurposing. Continue Reading
-
News
17 Apr 2024
CRN launches new labeling guidelines for melatonin supplements
Following a surge in melatonin-associated pediatric emergency department visits, the CRN is launching new labeling guidelines. Continue Reading
-
News
04 Apr 2024
Drawbridge Health's NanoDrop gains FDA clearance for at-home blood sampling
Drawbridge Health's FDA-cleared NanoDrop blood sampling lancet device offers convenient, painless, at-home blood testing. Continue Reading
-
News
29 Mar 2024
FDA approves $4.25 million gene therapy for MLD
After receiving FDA approval earlier this month, Orchard Therapeutics plans to price its new MLD gene therapy at $4.25 million. Continue Reading
-
Feature
18 Mar 2024
Exploring Transparency-Rx’s pharmacy benefit manager partners
This article explores "transparent" partners: SmithRx, Liviniti, AffirmedRx, RxPreferred, Navitus Health Solutions, Pharmacy Benefit Dimensions, Salvus, and MedOne. Continue Reading
-
News
15 Mar 2024
Eli Lilly partners with Amazon Pharmacy to deliver GLP-1 drugs
The partnership is helping support the company’s LillyDirect platform, which will now deliver drugs through Amazon or Truepill. Continue Reading
-
Answer
04 Mar 2024
Developing Quality Assurance Standards for Biologics, Biosimilars
Despite long-standing standards for small-molecule drugs, quality assurance guidelines for biologics and biosimilars are less robust and comprehensive. Continue Reading
-
Feature
28 Feb 2024
Continuous Manufacturing Revolutionizes Pharmaceutical Production
Continuous manufacturing transforms pharmaceutical production, enhancing efficiency and supply chain resilience. Continue Reading
-
News
28 Feb 2024
Amgen Opens Its Most Advanced Manufacturing Site in Central Ohio
On February 26, Amgen announced the opening of its most advanced manufacturing site located in New Albany, Ohio. Continue Reading
-
Feature
20 Feb 2024
Advancing Packaging Technologies for Climate-Adaptive Supply Chains
Advancing packaging tech for climate-adaptive pharma supply chains is crucial to protect product integrity, ensure patient safety, and minimize environmental impact. Continue Reading
-
Feature
07 Feb 2024
Advancing Sterility Assurance Through Environmental Monitoring
Environmental monitoring ensures pharmaceutical product safety by detecting and controlling contamination risks and maintaining quality standards. Continue Reading
-
News
02 Feb 2024
Breaking Down the Cost of Sickle Cell Disease Gene Therapies
As CMS attempts to navigate the astronomical costs of new sickle cell disease treatments, including gene therapy, it is critical to break down treatment costs. Continue Reading
-
Answer
29 Jan 2024
Exploring Gene and Cell Therapy Integration in Pharmacies
Integrating gene and cell therapy in pharmacies ensures accessibility, personalized care, and effective management, enhancing patient outcomes. Continue Reading
-
Answer
23 Jan 2024
Exploring and Managing GLP-1 Receptor Agonists in Weight Loss
As GLP-1 drugs like semaglutide become increasingly popular for weight loss, providers must optimize the tools and strategies they use to manage the medications. Continue Reading
-
Feature
22 Jan 2024
A Pulse Check on Advancements in the Life Sciences, Pharma Industry
A pulse check on the life sciences and pharmaceutical industry advancements highlights breakthroughs in gene therapy, targeted oncology, and male contraception. Continue Reading
-
News
03 Jan 2024
500 Drugs from Over 140 Brands Are Expected to Cost More This Year
Reuters broke the news that the approximately 500 drugs in the US are supposed to increase in January 2024. Continue Reading
-
Answer
12 Dec 2023
Exploring Data Analytics in Pharmaceutical Marketing
PharmaNewsIntelligence explores the role of data analytics in pharmaceutical marketing. Continue Reading
-
Feature
04 Dec 2023
Exploring Prescription Discount Cards’ Role in Medication Adherence
Prescription discount cards offer savings to patients without adequate insurance coverage, improving medication adherence. Continue Reading
-
Answer
20 Nov 2023
Exploring Pharmacy Benefit Manager Reforms: Transparency
PharmaNewsIntelligence explores the current PBM landscape and how transparency reform differs from current industry standards. Continue Reading
-
Feature
08 Nov 2023
8 Steps to Negotiating Successful Pharmaceutical Partnerships
Strategic pharmaceutical partnerships enable groundbreaking innovations and improve healthcare delivery. Continue Reading
-
Feature
07 Nov 2023
Are Therapeutic Advancements Impacting the Demand for Surgery?
The growing rate of innovative therapeutics and noninvasive alternatives may reduce the demand for surgery across the United States. Continue Reading
-
Feature
25 Oct 2023
Exploring Business Development Strategies for Pharma Startups
Exploring business development strategies for pharmaceutical startups is vital for innovation, patient care, economic growth, and global health challenges. Continue Reading
-
Answer
24 Oct 2023
Evaluating the Breast Cancer Therapeutics Market
An analyst at Citeline provided PharmaNewsIntelligence with insights into current trends, gaps, and predictions in the breast cancer therapeutics market. Continue Reading
-
Feature
17 Oct 2023
Ensuring Drug Safety Through Regulatory Compliance
Regulatory compliance ensures drug safety by enforcing standards, preventing harm, and ensuring quality control. Continue Reading
-
News
13 Oct 2023
Antifungal Therapeutic Drug Monitoring Are Rates Lower Than Use Rates
A recent survey of infectious disease specialists found that antifungal TDM rates are lower than recommended by the IDSA. Continue Reading
-
Feature
09 Oct 2023
10 Things to Know About the Updated 2023 COVID-19 Vaccines
Public awareness of the updated COVID-19, RSV, and flu vaccines is vital for informed decisions and protection against new strains. Continue Reading
-
News
09 Oct 2023
Controlling Oncology Costs with Cross-Benefit Drug Management
In the ever-changing oncology landscape, cross-benefit drug management tackles challenges, reduces costs, and shapes the future of care. Continue Reading
-
News
29 Sep 2023
Developing a Sustainable Pharmaceutical Workforce and Workplace
A collaborative report from the APhA, ASHP, and NABP provides strategies for improving pharmacy workplace conditions for a sustainable workforce. Continue Reading
-
News
25 Sep 2023
Escaping the Specialty Drug Tunnel with Cross-Benefit Strategies
Embracing cross-benefit strategies in specialty drug management enhances cost control and quality care and breaks free from the specialty drug tunnel. Continue Reading
-
Feature
19 Sep 2023
Can Pharmaceutical Companies Ethically Sponsor Medical Education?
Although pharmaceutical companies sponsor multiple aspects of medical education, these relationships present a moral gray area. Continue Reading
-
Feature
14 Sep 2023
Expanding Product Portfolios Through Technology Integration
Expanding product portfolios through technology integration streamlines diagnostics, telemedicine, and patient care, revolutionizing healthcare processes. Continue Reading
-
Feature
05 Sep 2023
7 Ways to Increase Pharmaceutical Sustainability
Enhancing pharmaceutical sustainability safeguards the planet's health while ensuring a vital global supply of medications. Continue Reading
-
Feature
28 Aug 2023
Dissecting Ethical Principles in the Pharmaceutical Industry
Multiple ethical dilemmas in the pharmaceutical industry impact industry members, providers, and patients. Continue Reading
-
Feature
10 Aug 2023
Assessing the Expected Impacts of OTC Hormonal Birth Control Pills
Newly approved OTC hormonal birth control pills are expected to improve contraceptive access, reduce healthcare spending, and save time. Continue Reading
-
News
20 Jul 2023
Comparing Merck and Pfizer’s 2022 ESG Ratings
Recent environmental, social, and governance metrics show how top pharmaceutical companies stack up in their pursuit of an equitable and sustainable future. Continue Reading
-
Answer
05 Jun 2023
Examining Challenges and the Potential of Integrating AI in Healthcare
Exploring AI integration in healthcare is crucial for improving outcomes and revolutionizing the medical industry. Continue Reading
-
Feature
17 May 2023
Applying Artificial Intelligence, Machine Learning in Cancer Care
In addition to the critical role artificial intelligence and machine learning play in the pharmaceutical industry, they have significant implications in advancing cancer detection, treatment, and recovery. Continue Reading
-
Feature
09 May 2023
Comparing Small Molecule and Biologics Drug Development Challenges
The development process for small molecule drugs and biologics is drastically different, presenting varying challenges for manufacturers, regulatory organizations, healthcare providers, and patients. Continue Reading
-
Answer
20 Mar 2023
Analyzing Returns on Investment from Pharmaceutical Innovation
It is increasingly critical for pharmaceutical innovation leaders to analyze returns on investments while managing their business practices. Continue Reading
-
News
03 Mar 2023
Eli Lilly Cuts Insulin Prices and Caps Monthly Out-of-Pocket Costs
In a recent announcement, Eli Lilly stated that it plans to cut insulin prices by 70% and cap out-of-pocket costs to $35 monthly. Continue Reading
-
Answer
28 Feb 2023
Analyzing 2023 Drug List Price Increases by Pharmaceutical Companies
To kick off the new year, an Ohio-based nonprofit analyzed drug list price increases by pharmaceutical companies in January 2023 using proprietary data. Continue Reading
-
News
17 Feb 2023
Cleveland Clinic Enrolls Patients in Breast Cancer Vaccine Trial
A news release by the Cleveland Clinic announces that it will begin enrolling high-risk but cancer-free patients in its preventative breast cancer vaccine trial. Continue Reading
-
Feature
07 Feb 2023
Comparing Global Pharmaceutical Markets: US, UK, and China
While contributing to the more significant global pharmaceutical market, the US, the UK, and China each have unique pharmaceutical markets managed by their respective regulatory organizations. Continue Reading
-
News
06 Feb 2023
CDC Analyzes Bivalent mRNA Vaccine Efficacy Against COVID Variants
In a recent Morbidity and Mortality Weekly Report, the CDC analyzed bivalent mRNA vaccine efficacy against existing COVID variants. Continue Reading
-
Answer
05 Feb 2023
Drug Repurposing May Benefit Rare Disease, Considerations, and Caveats
Drug repurposing may benefit the roughly 7,000 existing rare diseases for which there are limited research and treatment options; however, researchers and advocates must understand the considerations and caveats created by the current pharmaceutical industry standards. Continue Reading
-
News
01 Feb 2023
Abbvie Faces Competitor as a New Humira Biosimilar Comes to Market
On January 31, 2023, AbbVie faces a new competitor as Amgen releases a Humira biosimilar onto the market in the US. Continue Reading
-
News
25 Jan 2023
COVID Vaccine Uptake Among Immunocompromised Individuals Is Low
A recent study published in JAMA Network Open found that mRNA monovalent COVID vaccine uptake among immunocompromised individuals was low. Continue Reading
-
Feature
23 Jan 2023
Developing and Launching Drugs, Considerations, and Best Practices
Developing, launching, and marketing drugs can be complex and require multiple considerations by the company, the public, and regulatory agencies; however, following best practices can ensure a profitable and effective launch. Continue Reading
-
News
17 Jan 2023
Developing Next-Generation Respiratory Virus Vaccines, Considerations
NIH researchers published an article on necessary considerations for developing the next generation of respiratory virus vaccines for influenza, coronavirus, RSV, and more. Continue Reading
-
News
30 Dec 2022
FDA Advisory Committee to Discuss COVID Vaccine Regimens
In a recent press release, the director of the FDA’s Center for Biologics Evaluation and Research revealed its plans to convene an advisory committee to discuss COVID vaccine regimens. Continue Reading
-
Feature
20 Dec 2022
Challenges of Improving Access to Digital Therapeutics in Healthcare
As medicine and software converge, digital therapeutics are rapidly transforming healthcare, but manufacturers face several challenges that prevent patient access and widespread reimbursement. Continue Reading
-
News
20 Dec 2022
COVID Vaccines Have Prevented 3,255,656 Deaths
A recent analysis by the Commonwealth Fund found that COVID vaccine programs between December 12, 2020, and November 30, 2022, have prevented 3,255,656 deaths. Continue Reading
-
News
14 Dec 2022
Developing Next-Generation COVID Vaccines, an Urgent Need
In a recent viewpoint published in JAMA Network, clinicians call on researchers to develop a next-generation of COVID-19 vaccines, citing an urgent need to stay ahead of variants. Continue Reading
-
News
06 Dec 2022
Biosimilars in the US Cost 2.74 Times More Than in Other Countries
A recent analysis comparing biosimilar prices in the United States, Switzerland, and Germany found that biosimilars cost 2.74 times more in the US than in Switzerland and 1.94 times more compared to Germany. Continue Reading
-
Feature
06 Dec 2022
Disease-Modifying Antirheumatic Drugs Effectively Treat Arthritis
With 43.5% of arthritis patients experiencing some limitations, providers have begun to opt for disease-modifying antirheumatic drugs to treat rheumatoid arthritis effectively. Continue Reading
-
Answer
21 Nov 2022
Anticipating the 2023 Biosimilar Boom
As the comfort and familiarity of biosimilars have grown, many industry leaders anticipate a 2023 biosimilar boom, predicting that by 2028 the market will be worth $103.94 billion. Continue Reading
-
News
02 Nov 2022
COVID-19 Vaccine Side Effects Are Associated with Antibody Response
A recent article published in JAMA Network Open found a link between worse COVID-19 vaccine side effects and a more significant antibody response. Continue Reading
-
News
27 Oct 2022
FDA Data Shows That 125 Drugs Are Currently in Short Supply
FDA and pharmaceutical industry data show that drug shortages are cropping up for common classes of drugs, including antibiotics and psychotropics. Continue Reading
-
News
26 Oct 2022
FDA Awards 19 Grants for Rare Disease Research
In a recent press release, the FDA announced its awarding 19 grants and 2 contracts for rare disease research. Continue Reading
-
Feature
26 Oct 2022
Exploring the Benefits of a Collaborative Global Pharmaceutical Industry
As healthcare professionals call for collaboration, exploring the historical and projected benefits of a collaborative global pharmaceutical industry is necessary to incentivize industry leaders to contribute. Continue Reading
-
Feature
25 Oct 2022
Clinical Pharmacists Are a Major Contributor to Quality Patient Care
As the popularity of clinical pharmacists continues to rise, understanding their role, history, and benefits shows that they significantly contribute to quality patient care. Continue Reading
-
Answer
24 Oct 2022
Bridging Surgical Treatment and Chemoradiation for Glioblastoma Patients
A new technology that delivers postsurgical radiation may bridge the gap between surgical treatment and chemoradiation for patients with glioblastomas. Continue Reading
-
News
21 Oct 2022
AMA Analysis Finds Variations in PBM Competition
The AMA recently released an analysis of market shares and PBM competition in the United States which found variations at the state and metropolitan levels. Continue Reading
-
News
05 Oct 2022
Biologics and Biosimilars Intelligence Consortium Awarded $1.3 Million
Yesterday, the Biologics and Biosimilars Collective Intelligence Consortium announced that the FDA awarded it $1.3 million in grants. Continue Reading
-
Answer
04 Oct 2022
Combining Existing Drugs Introduced New Parkinson’s Disease Treatment
Researchers at Pharma Two B combined two existing Parkinson’s disease drugs to introduce a new treatment, a drug called P2B001. Continue Reading
-
News
03 Oct 2022
Drug Costs Are Not Justified by Research and Development Costs
In a cross-sectional study of 60 different drugs, researchers found that drug costs were not justified by research and development costs. Continue Reading
-
News
26 Sep 2022
Digital Health Tools Are Perceived as an Advantage to 93% of Physicians
A recent survey by the AMA found that 93% of physicians perceived digital health tools as advantageous in 2022, an 8% increase since 2016. Continue Reading
-
News
06 Sep 2022
FDA Announces That 35% of Drug Samples Were Non-Compliant
The FDA’s Report on The State of Pharmaceutical Quality announced that, in the 2021 fiscal year, the number of non-compliant drug samples increased to 35%, over twice as much as the 2020 fiscal year (FY). Continue Reading
-
Feature
23 Aug 2022
A History of Insulin Development and Insulin Delivery Systems
In recent years, insulin has caught media attention due to its increasing costs; understanding the basics of insulin and delivery systems can help us better understand how to address the prices. Continue Reading
-
News
19 Aug 2022
CVS Implements Time Delay Safes for Controlled Substances
A recent statement by CVS Health announced that they are implementing time delay safes for controlled substances. Continue Reading
-
News
18 Aug 2022
California Allots $100 Million to Produce Insulin, Improving Access
The state of California recently announced that it would allot approximately $100 million to the production of insulin biosimilars to improve insulin access. Continue Reading
-
Feature
10 Aug 2022
A History of Antivirals: Mechanisms, Classes, and Subtypes
Understanding the history, mechanisms, classes, and subtypes of antivirals may help inform the development and distribution of such drugs. Continue Reading
-
News
03 Aug 2022
$4.25 Billion Opioid Settlement by Teva Pharmaceuticals
Teva Pharmaceuticals — one of the biggest opioid producers in the world — has reached a tentative $4.25 billion opioid settlement. Continue Reading
-
Answer
25 Jul 2022
A New Liver Disease Diagnostic and Prevention Approach
A new software developed by Oncoustics may improve liver disease diagnosis and prevention. Continue Reading
-
News
21 Jul 2022
Depression, Anxiety Prescriptions Soar During Coronavirus Pandemic
A household survey conducted during the first two years of the coronavirus pandemic found a large increase in the number of mental health medications Americans were prescribed. Continue Reading
-
News
27 Jun 2022
Epilepsy Drug Prices Have Increased by 277% in the Past Decade
A recent statement from the American Academy of Neurology found that brand-name epilepsy drug prices have increased by 277% in the past decade. Continue Reading
-
News
21 Jun 2022
Beta Bionics Shares Clinical Trial Data on Bionic Pancreas for Type 1 Diabetes
Beta Bionics presented clinical trial data on an insulin-only Bionic Pancreas for type 1 diabetes at the American Diabetes Association Scientific Sessions. Continue Reading
-
News
14 Jun 2022
Eli Lilly Sued by Whistleblower for Pharmaceutical Manufacturing Issue
Drugmaker Eli Lilly terminated whistleblower Amrit Mula after she identified pharmaceutical manufacturing irregularities involving Trulicity — the company’s popular biologic diabetes medication. Continue Reading
-
News
23 May 2022
FDA Amends EUA For Pfizer-BioNTech’s COVID-19 Vaccine Booster
In other COVID news, AstraZeneca enters an agreement to develop COVID-19 antibodies and Novavax files for emergency use authorization of its COVID-19 vaccine in Taiwan. Continue Reading
-
News
18 May 2022
FDA Approves Eli Lilly and Company’s Type 2 Diabetes Injectable
In five clinical trials that evaluated three different doses of Eli Lilly’s Mounjaro, the drug improved blood sugar and was more effective than other types of 2 diabetes therapies. Continue Reading
-
News
05 May 2022
AstraZeneca to Open Drug Research, Development Site in MA
The strategic center will bring nearly 1,500 drug research and development, commercial, and corporate colleagues into a single purpose-built space in Cambridge, MA. Continue Reading
-
News
04 May 2022
Dr. Vishal Sikka to Join GSK as Non-Executive Director
Dr. Vishal Sikka joins GSK's board as non-executive director from the Haleon demerger and a board member of Oracle Corporation and BMW. Continue Reading
-
News
04 May 2022
FDA Expands Approval of COVID-19 Treatment, Remdesivir
In other COVID news, Moderna submits an emergency use authorization request for its COVID-19 vaccine and Novavax initiates administration of the first booster dose of its vaccine. Continue Reading
-
News
26 Apr 2022
FDA Considers New Strategy to Boost Safe Opioid Disposal
The modification to the existing Opioid Analgesic Risk Evaluation and Mitigation Strategy would provide a convenient disposal option for patients beyond those already available. Continue Reading
-
News
12 Apr 2022
FDA Approves ViiV Healthcare’s HIV-1 Treatment for Children
Other FDA approvals include Kite’s large B-cell lymphoma therapy, Yescarta, and Novartis’ drug for PIK3CA-Related Overgrowth Spectrum (PROS). Continue Reading
-
News
06 Apr 2022
FDA Expands Indication of Long-Acting Injectable HIV Treatment
Other recent FDA approvals include Novo Nordisk’s type 2 diabetes drug and a seizure treatment for patients two years of age and older. Continue Reading
-
News
31 Mar 2022
FDA Approves Second Dose of Moderna's COVID-19 Vaccine
In other recent COVID news, FDA expands the EUA for Pfizer and BioNTech's COVID-19 vaccine and Novavax announces the inclusion of its vaccine in two booster trials. Continue Reading
-
News
31 Mar 2022
FDA Declines Eli Lilly’s Letter for Non-Small Cell Lung Cancer Drug
FDA stated that it is unable to approve Eli Lilly’s application for its non-small cell lung cancer drug in its current form and recommended an additional multiregional clinical trial. Continue Reading
-
News
30 Mar 2022
FDA Approves Bristol Myers Antibody Combination for Melanoma
Other recent FDA approvals include Novartis’ prostate cancer drug and a second indication for Merck’s Keytruda for advanced endometrial carcinoma. Continue Reading
-
News
15 Mar 2022
FDA Approves Boehringer Ingelheim's Heart Failure Treatment
Other recent FDA approvals include Johnson & Johnson's multiple myeloma treatment and an expanded indication for Abbott's heart failure device. Continue Reading
-
News
11 Mar 2022
AMA Supports Biden's Medicare Proposal, Prescription Drug Policies
The AMA supports President Biden's proposal to reduce prescription drug costs for Medicare patients by including all pharmacy price concessions in the definition of "negotiated price." Continue Reading
-
News
10 Mar 2022
Boehringer Ingelheim, Lifebit Partner to Advance Biomedical Data
The companies will leverage Lifebit’s secure CloudOS platform to build scalable analytics and infrastructure platform to emphasize the value of biomedical data. Continue Reading
-
News
03 Mar 2022
FDA Accepts Bristol Myers’s BLA for Non-Small Cell Lung Cancer Drug
FDA based its decision on Phase 3 trial results, which showed that the non-small cell lung cancer drug plus chemotherapy improved complete response and event-free survival in patients. Continue Reading
-
News
03 Mar 2022
FDA Accepts Application for Pfizer’s Biosimilar to Humira
A study of the interchangeable biosimilar Abrilada met its primary goal of pharmacokinetic equivalence in patients who switched between treatment with Abrilada and Humira. Continue Reading